Silica nanoparticle-exposure during neuronal differentiation modulates dopaminergic and cholinergic phenotypes in SH-SY5Y cells

J Nanobiotechnology. 2019 Apr 1;17(1):46. doi: 10.1186/s12951-019-0482-2.

Abstract

Background: Silica-ε-polycaprolactone-nanoparticles (SiPCL-NPs) represent a promising tool for laser-tissue soldering in the brain. After release of the SiPCL-NPs in the brain, neuronal differentiation might be modulated. The present study was performed to determine effects of SiPCL-NP-exposure at different stages of neuronal differentiation in neuron-like SH-SY5Y cells. The resulting phenotypes were analyzed quantitatively and signaling pathways involved in neuronal differentiation and degeneration were studied. SH-SY5Y cells were differentiated with all-trans retinoic acid or staurosporine to obtain predominantly cholinergic or dopaminergic neurons. The resulting phenotype was analyzed at the end of differentiation with and without the SiPCL-NPs given at various times during differentiation.

Results: Exposure to SiPCL-NPs before and during differentiation led to a decreased cell viability of SH-SY5Y cells depending on the differentiation protocol used. SiPCL-NPs co-localized with the neuronal marker β-3-tubulin but did not alter the morphology of these cells. A significant decrease in the number of tyrosine hydroxylase (TH) immunoreactive neurons was found in staurosporine-differentiated cells when SiPCL-NPs were added at the end of the differentiation. TH-protein expression was also significantly downregulated when SiPCL-NPs were applied in the middle of differentiation. Protein expression of the marker for the dopamine active transporter (DAT) was not affected by SiPCL-NPs. SiPCL-NP-exposure predominantly decreased the expression of the high-affinity choline transporter 1 (CHT1) when the NPs were given before the differentiation. Pathways involved in neuronal differentiation, namely Akt, MAP-K, MAP-2 and the neurodegeneration-related markers β-catenin and GSK-3β were not altered by NP-exposure.

Conclusions: The decrease in the number of dopaminergic and cholinergic cells may implicate neuronal dysfunction, but the data do not provide evidence that pathways relevant for differentiation and related to neurodegeneration are impaired.

Keywords: Nanomedicine; Neuronal differentiation; Phenotype; Polymeric-nanoparticles; Toxicity.

MeSH terms

  • Cell Differentiation
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cholinergic Neurons / cytology
  • Cholinergic Neurons / drug effects*
  • Cholinergic Neurons / metabolism
  • Dopaminergic Neurons / cytology
  • Dopaminergic Neurons / drug effects*
  • Dopaminergic Neurons / metabolism
  • Humans
  • Nanoparticles / chemistry
  • Nanoparticles / toxicity*
  • Phenotype
  • Polyesters / chemistry
  • Polyesters / toxicity*
  • Signal Transduction
  • Silicon Dioxide / chemistry
  • Silicon Dioxide / toxicity*
  • Staurosporine / pharmacology
  • Tretinoin / pharmacology

Substances

  • Polyesters
  • polycaprolactone
  • Tretinoin
  • Silicon Dioxide
  • Staurosporine